EPO Endorses REPTA Deleterious Gene Policy
EPO is pleased to announce its endorsement of the Reptile & Exotic Pet Trade Association (REPTA, United Kingdom) Deleterious Gene Policy,
The policy represents an important step forward in addressing animal welfare concerns linked to the selective breeding of reptiles.
The REPTA Deleterious Gene Policy focuses on genetic traits—commonly referred to as “deleterious genes”—that are known to cause significant health and welfare issues in reptiles. These may include neurological, structural, metabolic, or other disorders that can severely impact an animal’s quality of life and longevity.
By endorsing this policy, EPO supports a science-based and responsible approach to reptile breeding that prioritizes animal welfare.
The policy calls on breeders, traders, and other stakeholders to:
- Refrain from producing, selling, or acquiring reptile morphs associated with serious welfare concerns
- Promote transparency across the supply chain, including clear communication with buyers
- Improve consumer awareness and education on the welfare implications of certain genetic traits
- Maintain and regularly review a list of morphs with demonstrated harmful effects
EPO recognises the REPTA Deleterious Gene Policy as a valuable industry-led initiative that contributes to improving standards and fostering responsible practices within the reptile sector.
This endorsement reflects EPO’s continued commitment to promoting high standards of animal welfare across all companion animal sectors, including reptiles.
Further Information
The full REPTA Deleterious Gene Policy is available here:
